Market Overview
The animal blood bank market provides critical blood products, including whole blood, plasma, and packed red blood cells, for veterinary transfusion medicine. These services support surgical procedures, trauma care, and the treatment of conditions such as anemia, clotting disorders, and immune-mediated diseases in animals. Blood banks operate through both commercial entities and non-profit organizations, sourcing donations primarily from healthy companion animals.
- •Products include whole blood, fresh frozen plasma, packed red blood cells, and cryoprecipitate
- •Primary donor animals are dogs and cats, with equine blood banking also significant
- •Recipients include companion animals undergoing surgery, trauma cases, and animals with hematological conditions
Growth Drivers
The market's growth is largely fueled by the rising global pet population and increased spending on companion animal healthcare. Advances in veterinary medicine have expanded the range of procedures requiring blood products, while greater awareness of pet blood donation programs has improved donor availability. Additionally, the trend toward pet humanization has led owners to pursue more sophisticated and costly treatments, including those involving blood-based therapies.
- •Rising companion animal ownership and increased pet healthcare expenditure
- •Advances in veterinary surgical and diagnostic procedures requiring transfusion support
- •Growing awareness and participation in community pet blood donation programs
Segmentation and Regional Analysis
The market is segmented by animal type, primarily canine, feline, and equine, as well as by product type including whole blood, plasma components, and red blood cell concentrates. Geographically, North America leads the market due to high pet ownership rates, advanced veterinary infrastructure, and established blood banking networks. Europe follows, supported by strong animal welfare regulations and growing veterinary specialization, while the Asia-Pacific region presents emerging opportunities.
- •Canine blood products represent the largest segment by volume
- •North America accounts for the largest regional share, followed by Europe
- •Asia-Pacific is the fastest-growing regional market
Competitive Landscape
Who are the notable companies in the industry?
The global animal blood bank market is shaped by a diverse mix of commercial operators and specialized service providers, each differentiated by distribution model and product breadth. Animal Blood Resources International stands as a major commercial network spanning North America with an extensive portfolio. Hemopet differentiates itself through its mobile donation program and integrated product ecosystem, while Blue Ridge Veterinary Blood Bank and HemoSolutions compete on regional donor-network strength and service reliability. Nine Lives Blood Services and BodeVet serve distinct geographic and clinical niches, leveraging targeted outreach to veterinary practices. PLASVACC and its U.S. counterpart PLASVACC USA Inc. focus on plasma-derived products and immunoglobulin therapies, carving out a specialized segment within the broader market. Together, these players illustrate a competitive landscape defined by operational scale, geographic reach, and product specialization rather than price alone.
- •Animal Blood Resources International operates commercial blood banking services across multiple US locations
- •HemoPet manages a well-known bloodmobile program for canine donations
- •Pet Blood Bank UK and Canadian Animal Blood Bank serve regional markets with community-sourced donations
Trends and Outlook
What are the recent trends and outlook?
Looking ahead, the market is expected to continue its steady expansion as veterinary medicine becomes increasingly sophisticated. Emerging trends include the development of synthetic blood alternatives and oxygen carriers, which could eventually complement traditional blood products. Digital platforms for managing donor registries and improving blood matching between donors and recipients are also gaining adoption across the industry.
- •Research into synthetic oxygen-carrying blood substitutes is progressing for veterinary applications
- •Digital donor management and blood typing databases are improving matching efficiency
- •Industry consolidation and expansion of distribution networks are expected to continue
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.